s-adenosylmethionine has been researched along with Parkinson Disease, Secondary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramsden, DB; Williams, AC | 1 |
| Charlton, CG; Lamango, NS | 1 |
| Charlton, CG; Crowell, B | 1 |
1 review(s) available for s-adenosylmethionine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Autotoxicity, methylation and a road to the prevention of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Humans; Methylation; Niacinamide; Parkinson Disease; Parkinson Disease, Secondary; Risk Factors; S-Adenosylmethionine | 2005 |
2 other study(ies) available for s-adenosylmethionine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Chromatography, Gel; Cysteine; Freeze Drying; Male; Methylation; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; S-Adenosylmethionine; Stereotyped Behavior; Sympathectomy, Chemical; Tremor | 2000 |
Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa.
Topics: Animals; Behavior, Animal; Histocytochemistry; Injections, Intraventricular; Levodopa; Male; Nerve Degeneration; Parkinson Disease, Secondary; Psychomotor Performance; Rats; Rats, Sprague-Dawley; S-Adenosylmethionine; Substantia Nigra; Tremor; Tyrosine 3-Monooxygenase | 1992 |